老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

传奇生物

28.29
-0.4700-1.63%
盘后：28.290.00000.00%16:20 EDT
成交量：99.74万
成交额：2,831.12万
市值：52.14亿
市盈率：-23.77
高：28.85
开：28.71
低：28.13
收：28.76
数据加载中...
总览公司新闻公告
2022/10/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/30

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/16

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/07/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/09

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/04

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/06/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/02

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/02

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/29

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/05/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/19

SEC问询函

CORRESP [Cover] - Correspondence
更多